🎉 M&A multiples are live!
Check it out!

GeneDx Valuation Multiples

Discover revenue and EBITDA valuation multiples for GeneDx and similar public comparables like 4basebio, Genus, and ToolGen.

GeneDx Overview

About GeneDx

GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world’s substantial rare disease data sets.


Founded

2020

HQ

United States of America
Employees

1K+

Website

genedx.com

Financials

LTM Revenue $321M

LTM EBITDA $20.5M

EV

$2.8B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

GeneDx Financials

GeneDx has a last 12-month revenue of $321M and a last 12-month EBITDA of $20.5M.

In the most recent fiscal year, GeneDx achieved revenue of $305M and an EBITDA of -$1.3M.

GeneDx expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See GeneDx valuation multiples based on analyst estimates

GeneDx P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $203M $305M XXX XXX XXX
Gross Profit -$26.8M $90.0M XXX XXX XXX
Gross Margin -13% 29% XXX XXX XXX
EBITDA -$136M -$1.3M XXX XXX XXX
EBITDA Margin -67% 0% XXX XXX XXX
Net Profit -$549M -$176M XXX XXX XXX
Net Margin -271% -58% XXX XXX XXX
Net Debt n/a n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

GeneDx Stock Performance

As of April 15, 2025, GeneDx's stock price is $101.

GeneDx has current market cap of $2.8B, and EV of $2.8B.

See GeneDx trading valuation data

GeneDx Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$2.8B $2.8B XXX XXX XXX XXX $0.44

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

GeneDx Valuation Multiples

As of April 15, 2025, GeneDx has market cap of $2.8B and EV of $2.8B.

GeneDx's trades at 8.8x LTM EV/Revenue multiple, and 137.3x LTM EBITDA.

Analysts estimate GeneDx's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for GeneDx and 10K+ public comps

GeneDx Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $2.8B XXX XXX XXX
EV/Revenue 9.2x XXX XXX XXX
EV/EBITDA -2231.0x XXX XXX XXX
P/E -54.2x XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF -82.7x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get GeneDx Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

GeneDx Valuation Multiples

GeneDx's NTM/LTM revenue growth is 17%

GeneDx's revenue per employee for the last fiscal year averaged $0.3M, while opex per employee averaged $0.2M for the same period.

Over next 12 months, GeneDx's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate GeneDx's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for GeneDx and other 10K+ public comps

GeneDx Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth 51% XXX XXX XXX XXX
EBITDA Margin 0% XXX XXX XXX XXX
EBITDA Growth -99% XXX XXX XXX XXX
Rule of 40 (SaaS-only) 17% XXX XXX XXX XXX
Revenue per Employee $0.3M XXX XXX XXX XXX
Opex per Employee $0.2M XXX XXX XXX XXX
S&M Expenses to Revenue 22% XXX XXX XXX XXX
G&A Expenses to Revenue 33% XXX XXX XXX XXX
R&D Expenses to Revenue 15% XXX XXX XXX XXX
Opex to Revenue 71% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

GeneDx Public Comps

See public comps and valuation multiples for Genomics & Personalized Medicine and Health Data & Analytics comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
EZZ Life Science XXX XXX XXX XXX XXX XXX
Epigenomics XXX XXX XXX XXX XXX XXX
ToolGen XXX XXX XXX XXX XXX XXX
4basebio XXX XXX XXX XXX XXX XXX
Genus XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

GeneDx M&A and Investment Activity

GeneDx acquired  XXX companies to date.

Last acquisition by GeneDx was  XXXXXXXX, XXXXX XXXXX XXXXXX . GeneDx acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by GeneDx

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About GeneDx

When was GeneDx founded? GeneDx was founded in 2020.
Where is GeneDx headquartered? GeneDx is headquartered in United States of America.
How many employees does GeneDx have? As of today, GeneDx has 1K+ employees.
Who is the CEO of GeneDx? GeneDx's CEO is Ms. Katherine A. Stueland.
Is GeneDx publicy listed? Yes, GeneDx is a public company listed on NAS.
What is the stock symbol of GeneDx? GeneDx trades under WGS ticker.
When did GeneDx go public? GeneDx went public in 2021.
Who are competitors of GeneDx? Similar companies to GeneDx include e.g. EZZ Life Science, Epigenomics, ToolGen, 4basebio.
What is the current market cap of GeneDx? GeneDx's current market cap is $2.8B
What is the current revenue of GeneDx? GeneDx's last 12-month revenue is $321M.
What is the current EBITDA of GeneDx? GeneDx's last 12-month EBITDA is $20.5M.
What is the current EV/Revenue multiple of GeneDx? Current revenue multiple of GeneDx is 8.8x.
What is the current EV/EBITDA multiple of GeneDx? Current EBITDA multiple of GeneDx is 137.3x.
What is the current revenue growth of GeneDx? GeneDx revenue growth between 2023 and 2024 was 51%.
Is GeneDx profitable? Yes, GeneDx is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.